The world’s worst outbreak of the Ebola virus – which has killed more than 1,000 people in West Africa so far this year – is fuelling efforts to speed vaccine and drug development.
Numerous high-profile laboratories around the world are focusing intently on experimental vaccines and other drugs. At present, the initial tests and results are showing mixed benefits for those infected with the virus and creating fresh research challenges for the pharmaceutical companies.
Click on the graphic for an expanded view.
Engineering & Technology magazine 